Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Delta-Fly Pharma, Inc. (JP:4598)
TSE/TYO:4598
Holding JP:4598?
Track your performance easily
4598 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥445.00 - ¥1,078.00
Previous Close¥677
Volume764.30K
Average Volume (3M)850.39K
Market Cap
¥6.10B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-216.75
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume850,390
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4598 FAQ
What was Delta-Fly Pharma, Inc.’s price range in the past 12 months?
Delta-Fly Pharma, Inc. lowest stock price was ¥445.00 and its highest was ¥1078.00 in the past 12 months.
What is Delta-Fly Pharma, Inc.’s market cap?
Currently, no data Available
When is Delta-Fly Pharma, Inc.’s upcoming earnings report date?
Delta-Fly Pharma, Inc.’s upcoming earnings report date is Feb 18, 2025 which is in 57 days.
How were Delta-Fly Pharma, Inc.’s earnings last quarter?
Delta-Fly Pharma, Inc. released its earnings results on Nov 14, 2024. The company reported -¥50.66 earnings per share for the quarter, missing the consensus estimate of N/A by -¥50.66.
Is Delta-Fly Pharma, Inc. overvalued?
According to Wall Street analysts Delta-Fly Pharma, Inc.’s price is currently Overvalued.
Does Delta-Fly Pharma, Inc. pay dividends?
Delta-Fly Pharma, Inc. does not currently pay dividends.
What is Delta-Fly Pharma, Inc.’s EPS estimate?
Delta-Fly Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delta-Fly Pharma, Inc. have?
Delta-Fly Pharma, Inc. has 9,010,000 shares outstanding.
What happened to Delta-Fly Pharma, Inc.’s price movement after its last earnings report?
Delta-Fly Pharma, Inc. reported an EPS of -¥50.66 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.506%.
Which hedge fund is a major shareholder of Delta-Fly Pharma, Inc.?
Currently, no hedge funds are holding shares in JP:4598
---
Technical Analysis
Symbio Pharmaceuticals Limited
―
StemRIM Inc.
―
Modalis Therapeutics Corporation
―
CellSource Co., Ltd.
―
---